1. Introduction {#sec1}
===============

Ferrocenyl derivatives bearing heteroatoms, such as N, P and S, have been of great importance in organometallic chemistry. The synthesis of compounds containing the ferrocenyl unit with various acceptor units such as pyrrole \[[@bib1]\], indole \[[@bib2]\], thiourea \[[@bib3]\], pyridine \[[@bib4]\] and imidazole \[[@bib5]\] have been previously reported. These particular ferrocenyl derivatives have potential applications in fields such as electrochemistry \[[@bib6]\], medicinal science \[[@bib7]\], nonlinear optics \[[@bib8]\] and materials science \[[@bib9], [@bib10]\]. Ferrocenyl alkyl azoles have received considerable attention as a result of the unusual properties of the ferrocene system, and this is due to its unique steric protection, electron-donation properties and chemical stability \[[@bib11]\]. The design and fabrication of series of donor-acceptor systems are increasing due to their use in the preparation of optoelectronics \[[@bib12]\], liquid crystals \[[@bib13]\], polymers \[[@bib14]\], sensors \[[@bib15]\] and magnetic materials \[[@bib16]\]. The photonic and electronic properties of the donor-acceptor system can be fine-tuned by varying the acceptor, donor or spacer strength \[[@bib17]\].

Several synthetic approaches have been exploited for the synthesis of ferrocenylalkyl azoles. Mono- and di-substituted ferrocenyl compounds with *N*-heterocyclic groups, such as ferrocenylmethylbenzimidazole, have been reported \[[@bib18]\]. Ferrocenylmethyl benzimidazole has been prepared according to the classical method, i.e. from the reaction of thionyldibenzimidazole and ferrocenylmethanol in dichloromethane \[[@bib19]\]. 1-Ferrocenylethyl benzotriazole has also been synthesized by using 1-ferrocenylethanol and benzotriazole in dichloromethane in the presence of aqueous fluoroboric acid at room temperature \[[@bib20]\]. An alternative approach for the synthesis of ferrocenylalkyl imidazoles has been proposed with the use of *N,N′*-carbonyldiimidazole (CDI) \[[@bib16]\]. For example, 1,1′-bis(imidazolylmethyl)ferrocenes have been synthesized by the reaction of diferrocenemethanol with CDI \[[@bib21]\] or phosphorous tribromide \[[@bib5]\]. Simenel *et al.* \[[@bib22]\] reported a simple method for the synthesis of ferrocenyl(alkyl)imidazoles. This method involves the treatment of ferrocenylcarbinols with CDI in methylene dichloride. Additionally*, N,N′-*diferrocenylimidazol(in)ium salts have been synthesized by condensation of *N,N*′-diferrocenyldiazabutadiene with formaldehyde \[[@bib23]\]. The electrochemical behaviour of a range of ferrocenylalkyl azoles has been studied and the compounds were found to have low reduction potentials \[[@bib24], [@bib25]\]. The oxidation potentials (E~pa~) for substituted ferrocenylalkyl azoles have been found to be markedly dependent on the degree of electron-accepting or electron-donating properties of the lateral substituents \[[@bib26]\].

In terms of applications, a number of ferrocenyl imidazole salt derivatives ferrocenyl imidazole salts, have been utilized in various applications. For example, ferrocenylalkyl imidazole salts have been found to play a vital role in many biological systems such as metallo-proteins \[[@bib27]\] and anticancer drugs \[[@bib18]\]. Ferrocenyl compounds connected to an imidazole ring, such as ferrocenylethyl-*N′-*(trimethylphenyl)imidazole chloride have been found to show antimicrobial activity \[[@bib28]\]. Substituted ferrocenyl imidazoles have also been employed as the catalyst for the synthesis of nitrogen-doped carbon nanotubes (N-CNTs) and N-CNT-metal nanocomposites \[[@bib11], [@bib29]\]. These compounds have produced carbon nanomaterials with improved thermal \[[@bib30], [@bib31]\], structural \[[@bib32]\] and magnetic \[[@bib33]\] properties.

In this study, we report the synthesis and characterization of -Cl, -NO~2~ and -CH~3~ substituted ferrocenyl imidazole compounds. The synthesis of 1-ferrocenylmethyl(2-chloroimidazole) (**1**), 1-ferrocenylmethyl(2-nitroimidazole) (**2**) and 1-ferrocenylmethyl(2-methylimidazole) (**3**) have been reported in our previous work \[[@bib29]\], however, the synthesis of 1,1′-ferrocenylmethyl(2-chloroimidazole) (**4**), 1,1′-ferrocenyl(2-nitroimidazole) (**5**) and 1,1′-ferrocenylmethyl(2-methylimidazole) (**6**) are reported for the first time. The structure-property relationships of compounds **1--6** were investigated. The redox behaviour and electronic transitions of compounds **1**--**6** were investigated by both experimental (cyclic voltammetry and UV-visible spectroscopy, respectively) and theoretical (density functional theory (DFT) calculations) studies. The molecular structures of compounds **4** and **5** were determined by X-ray crystallography.

2. Results and discussion {#sec2}
=========================

2.1. Synthesis and characterization {#sec2.1}
-----------------------------------

Mono- (**1**--**3)** and di-substituted (**4--6)** ferrocenyl imidazole compounds were synthesized following a literature method, i.e. the reaction of ferrocenemethanol and 1,1′-ferrocenedimethanol, respectively, with 2-substituted (-Cl, -NO~2~ and -CH~3~) 1H-imidazoles in the presence of glacial acetic acid \[[@bib34]\] ([Scheme 1](#sch1){ref-type="fig"}). Compound **4** is an orange solid, while compounds **5** and **6** are high melting compounds obtained as yellow solids. All compounds were obtained in relatively high isolated yields (75--83%), similar to those reported in the synthesis of ferrocenyl alkyl imidazole compounds, obtained from the reaction of ferrocenemethanol \[[@bib35]\] and 1,1′-ferrocenedimethanol \[[@bib5]\]. From ^1^H-NMR spectra, characteristic resonances for imidazole protons appeared at 6.77--7.66 ppm and at 124.87--132.43 ppm for C5/C6 in the case of ^13^C-NMR spectra ([Table 1](#tbl1){ref-type="table"}, Figs. [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). These values are similar to those reported for ferrocenyl(methyl)imidazole \[[@bib36]\].Scheme 1Reaction schemes of (a) ferrocenemethanol and (b) 1,1′-diferrocenemethanol for the synthesis of compounds **1--6**.Scheme 1Table 1^1^H-/^13^C-NMR characteristic data for the imidazole moiety of compounds **1**--**6**.Table 1Compound^1^H-NMR (ppm)^13^C-NMR (ppm)C3-HC5/C6-HC3C4C5/C6**1**[∗](#tbl1fnlowast){ref-type="table-fn"}4.756.78/6.8181.81120.65127.93/131.22**2**[∗](#tbl1fnlowast){ref-type="table-fn"}5.346.92/7.0180.15144.47124.87/128.04**3**[∗](#tbl1fnlowast){ref-type="table-fn"}4.736.76/6.8482.78143.94128.70/130.87**4**4.766.85/6.8982.87131.22128.15/130.87**5**5.387.15/7.6681.57124.97128.23/128.25**6**4.766.77/6.8283.66143.92128.79/132.46[^1]Fig. 1^1^H-NMR of compounds (a) **4** (b) **5** and (c) **6**.Fig. 1Fig. 2^13^C-NMR of compounds (a) **4** (b) **5** and (c) **6**.Fig. 2

The resonance peaks of the unsubstituted ferrocenes and the substituted ferrocenes occur as a singlet between 4.12-4.23 ppm and as a triplet between 4.22-4.27 ppm, respectively \[[@bib37]\]. The peak for C3-H was observed to be more downfield, i.e. 5.34 ppm for **2** and 5.38 ppm for **5**, and this due to the electron-withdrawing inductive effect from the -NO~2~ substituent ([Fig. 1](#fig1){ref-type="fig"} and [Scheme 1](#sch1){ref-type="fig"}).

The appearance of a FTIR absorption band between 1248-1360 cm^−1^ was observed in all compounds. This peak marked the appearance of the C-N absorption band while the O-H bands of the starting ferrrocenyl alcohols disappeared. The most important frequencies for the ferrocene moiety are found at 450--481 (ν~Fe--Cp~), 821--831 (πC--H), 1440 cm^−1^ (ν~C--C~) and 3382-3113 cm^−1^ (ν~C--H~) \[[@bib37]\].

2.2. Crystal structures {#sec2.2}
-----------------------

Crystals of compounds **4** and **5** were grown in a dichloromethane-hexane solution. *ORTEP* drawings of these compounds together with the atom numbering schemes, are shown in [Fig. 3](#fig3){ref-type="fig"}. Selected bond angles and bond lengths for compounds **4** and **5** are listed in [Table 2](#tbl2){ref-type="table"}. The asymmetric unit of compound **4** contains one molecule while for compound **5** it contains half a molecule with the other half generated by the inversion centre on the Fe atom. The Cp rings in compound **5** adopt a perfect *anti*-conformation with a staggering angle of 35.82(4)°. In compound **4**, the Cp rings of the ferrocene units are slightly twisted from the ideal eclipsed conformation with C-centroid-centroid-C torsion angles of 11.46(8)°. The Cp rings in compound **4** were slightly tilted by an average angle of 2.25(3)°.Fig. 3*ORTEP* diagrams, along with the atom-numbering scheme for compounds (a) **4** and (b) **5**. The thermal ellipsoids are depicted at 50% probability.Fig. 3Table 2Selected bond lengths (Å) and angles (°) for compounds **4** and **5**.Table 245C(1)-C(11)1.503(2)C(1)-C(6)1.496(2)C(11)-N(1)1.469(8)C(6)-N(1)1.487(8)N(2)-C(13)-N(1)114.08(13)N(1)-C(7)-N(2)121.76(14)N(1)-C(11)-C(1)112.28(12)C(7)-N(1)-C(6)132.00(13)C(11)-C(1)-C(6)-C(15)79.42(1)C(6)-C(1)-C(1)-C(6)180C(4)-C(5)-C(1)108.17(13)C(1)-C(2)-C(3)108.13(14)C(2)-Fe(1)2.045(14)C(2)-Fe(1)2.042(6)C(5)-Fe(1)2.034(14)C(5)-Fe(1)2.036(15)

The N-C-N imidazole angles are 121.25° (N1-C13-N2) and 113.96° (N1-C7-N2) in compounds **4** and **5**, respectively; and are larger than the values for imidazole salts (107.6--108.7°) reported by Gao *et al.* \[[@bib22]\]. This increase in bond angle could be attributed to the electron-withdrawing effect of the -Cl and -NO~2~ substituents on the imidazole rings \[[@bib38], [@bib39]\]. In compound **4**, the dihedral angles between the planes of the substituted Cp rings and the imidazole ring plane are 65.58(5)°and 67.28(2)°, respectively, while in compound **5**, the dihedral angles are equal with a value of 71.46°(4). This slight change in the dihedral angle is probably due to the steric effect of the substituents on the imidazole moiety and the Cp rings \[[@bib40]\]. The crystallographic data and structural refinement parameters for compounds **4** and **5** are shown in [Table 3](#tbl3){ref-type="table"}.Table 3Crystallographic data and structural refinement parameters for compounds **4** and **5**.Table 345Empirical formulaC~18~H~16~Cl~2~FeN~4~C~18~H~16~FeN~6~O~4~Formula weight411.07436.22T(K)173(2)100(2)λ (Å)0.710730.71073Crystal systemMonoclinicMonoclinicSpace group*P*2~1~/*nC*2/*c*Unit cell dim. (Å/°)*β*102.9480(10)°102.539(2)°*a*8.5123(3)10.9972(3)*b*15.7406(6)7.5371(2)*c,*13.1687(5)21.7869(7)V(Å^3^)1719.59(11)1762.78(9)Z44*σ* (Mg/m^3^)1.5881.644*μ*(mm^−1^)1.1950.897*F* (000)832896Crystal size (mm^3^)0.326 × 0.319 × 0.2720.220 × 0.160 × 0.080θ range (°)2.047 →27.4611.915 → 28.321Index ranges-10 ≤ *h* ≤ 10\
-20 ≤ *k* ≤ 9\
-16 ≤ *l* ≤ 16-11 ≤ *h* ≤ 14\
-9 ≤ *k* ≤ 9\
-29 ≤ *l* ≤ 26Reflections collected228478361Independent reflections32882173Completeness to θ %/(°)s99.9 (25.242)Data/restrs/para3288/0/2262173/0/133GOOF on *F*^*2*^1.0731.035Final *R* indices, *R*~*1*~*, wR*~*2*~ \[I \> 2sigma(I)\]0.0289, 0.08110.0299, 0.0734*R* indices (all data), *R*~*1*~*, wR*~*2*~0.0305, 0.08240.0400, 0.0793Largest diff. peak & hole0.946 and -0.288 e.Å^−3^0.502 and -0.314 e.Å^−3^

2.3. UV-visible absorption spectroscopic studies {#sec2.3}
------------------------------------------------

The absorption spectra for compounds **1**--**6** are shown in [Fig. 4](#fig4){ref-type="fig"} and the relevant absorption characteristics are given in [Table 4](#tbl4){ref-type="table"}. The spectra obtained in acetonitrile show bands at approximately 328 and 438 nm. The bands at 328 nm represent π-π\* transitions from the ferrocenyl to the imidazole moiety, while the bands at 438 nm are ascribed to *d*-*d* transitions, probably mixed with *d*-π\* transitions \[[@bib41]\]. There is a shift of the π-π\* band of compounds **2** and **5**, at 328 nm bathochromically to 331 nm, attributed to the stronger electron-withdrawing effect of the nitro group on the imidazole moiety \[[@bib42], [@bib43]\]. This shift could also be attributed to the strong electronic communication between the enriched imidazole and ferrocenyl moieties \[[@bib44]\].Fig. 4UV-visible spectra of 0.005M solutions of **1**-**6** in acetonitrile.Fig. 4Table 4UV-visible absorption characteristics of compounds **1**--**6**.Table 4Compoundsλ~max~/nm (molar absorptivity/mol^−1^ dm^3^ cm^−1^)*d*-*d*π-π\***1**438 (174)328 (89)**2**none331 (236)**3**438 (138)328 (142)**4**433 (173)328 (141)**5**none331 (241)**6**437 (172)328 (249)

In order to establish the solvatochromic behaviour of compounds **1**, **3**, **4** and **6**, absorption studies were carried out in different solvents, that is, dimethylformamide (DMF) (polar aprotic), methanol (polar protic), acetonitrile (polar aprotic) and dichloromethane (DCM) (mid-polar aprotic). In all compounds, two bands (*d*-*d* transition and charge transfer (CT)) are observed. The data obtained are summarized in [Table 5](#tbl5){ref-type="table"}. CT transitions usually display a large solvent-dependent effect \[[@bib45]\], resulting in negative solvatochromism as observed in methanol and DMF when compared with DCM ([Fig. 5](#fig5){ref-type="fig"}). This could be attributed to possible hydrogen-bonding between the compounds and the polar solvent molecules. It was found that the CT absorption band in compounds **1**, **3**, **4** and **6** is the same in all solvents; however, a red shift in the π-π\* absorption band was observed upon a change in solvent polarity with compound **1** (showing the most significant shift from λ~max~ = ∼320 nm methanol/DMF to DCM) ([Fig. 5](#fig5){ref-type="fig"}). Thus, the electron-withdrawing and electron-donating substituents influenced the dipole-dipole interactions between the compounds and solvents \[[@bib46]\]. Similar behaviour has been reported for ferrocenyl imidazole derivatives \[[@bib47]\].Table 5Absorption wavelengths of ferrocenyl imidazole derivatives in DCM, methanol, DMF and acetonitrile.Table 5Compoundsλ~max~/nmDCMMethanolDMFAcetonitrile**1**none438440438343321320321**2**nonenonenonenone328327327331**3**436429436428334320322321**4**446434442427331326328328**5**nonenonenonenone329325327331**6**430427438438332326327328Fig. 5UV-visible spectra of 0.005 M solutions of compound **1** in DMF, acetonitrile, methanol and DCM.Fig. 5

2.4. Electrochemical studies {#sec2.4}
----------------------------

Electrochemical studies of compounds **1**--**6** were performed in acetonitrile, with NaClO~4~ (0.5 M) as the supporting electrolyte, at a scan rate of 100 mV/s. [Fig. 6](#fig6){ref-type="fig"} shows the cyclic voltammograms (CV), while the corresponding electrochemical data are presented in [Table 6](#tbl6){ref-type="table"}. The CV of the substituted ferrocenyl imidazole compounds exhibit the electrochemical oxidation wave of the ferrocene/ferrocenium ion, and this is coupled with a quasi-reversible peak. Compounds **1**--**6** show one fully or partially reversible one-electron oxidation and one or two quasi-reversible reductions for the imidazole acceptor moieties. The ferrocenyl moieties in compounds **1**--**6** show larger E~pa~ values than free ferrocene. The E~pa~ values follow the order: **5** \> **4** \> **2** \> **3** \> **1** \> **6**, which can be related to the effect of the substituents on the redox potential of the compounds and, subsequently, the electron transfer process. Compounds **1--6** gave i~pa~/i~pc~ ratios of approximately 1. As expected, the introduction of electron-withdrawing -Cl and -NO~2~ substituents led to a more positive shift in the redox potential \[[@bib48]\].Fig. 6Cyclic voltammogram of compounds (a) **1**--**3** and (b) **4**--**6** in 0.5 M NaClO~4~**/**acetonitrile at a platinum working electrode.Fig. 6Table 6Cyclic voltammetry data for compounds **1**--**6**.Table 6CompoundE~pa~ (mV)E~pc~ (mV)ΔE~p~ (mV)$E_{1/2\text{~\!}}$ (mV)i~pa~/i~pc~Ferrocene \[[@bib52]\]470413574421.170**1**446373734101.129**2**456385714211.279**3**452376764141.168**4**546475715111.111**5**560484765221.014**6**426353733901.075[^2]

The CV curves of compounds **2** and **5** showed poorly resolved ferrocene-based waves ([Fig. 6](#fig6){ref-type="fig"}a and b). Probably the use of a coordinating solvent (i.e. acetonitrile**)** masked irregular features of the CV curves for compounds **2** and **5**. The two observed waves for compounds **1**, **3**, **4** and **6** are associated with the typical symmetrical dimers which produce a mixed valent transition upon reduction or oxidation. Reductions potentials on the side groups of symmetrical complexes that generate mixed valent intermediates have been reported \[[@bib49]\]. These systems either allow electron delocalization from direct metal-metal interaction or through the bridge path. The mixed valent intermediate group of the ferrocenyl and the ferrocenium group could be influenced by the electronegativities of the attached group.

$E_{1/2}$ of mono-substituted derivatives, compounds **1**--**3**, is between 410-421 mV, while the di-substituted derivatives, compounds **4**--**6**, displayed $E_{1/2\text{~\!}}$ values in the range of 390--522 mV. Compound **5** has the highest $E_{1/2\text{~\!}}$ values, thus higher reduction propensity, while compound **6** gave the lowest $E_{1/2\text{~\!}}$value indicating less favourable reduction of the Fe centre. From our results, compounds **2**, **4** and **5** show relatively high $E_{1/2\text{~\!}}$ values (421, 511 and 522 mV, respectively), corresponding to the oxidation of the ferrocenyl moiety, attributable to the electron-withdrawing effect of the -Cl and -NO~2~ substituents on the imidazole moiety, compared with compounds **1**, **3** and **6** \[[@bib5],[@bib50],[@bib51]\]. The $E_{\text{pa}}$ values for mono- and di-substituted ferrocenyl derivatives were shifted to more positive potentials (426--560 mV) compared with that of unsubstituted ferrocene (413 mV) ([Table 6](#tbl6){ref-type="table"}).

2.5. Theoretical calculation {#sec2.5}
----------------------------

To obtain a better insight into the electronic nature and electrochemical properties of compounds **1**--**6**, DFT calculations were carried out with the B3LYP functional and M06-L with def2-TZVP. The optimized geometries of compounds **4** and **5** were in good agreement with the experimental ones obtained from single crystal XRD analysis ([Fig. 3](#fig3){ref-type="fig"}).

The molecular orbitals considered were the second highest (HOMO-1) and highest (HOMO) occupied once and the lowest (LUMO) and second-lowest (LUMO+1) unoccupied ones. [Fig. 7](#fig7){ref-type="fig"} shows the frontier molecular orbitals (HOMO and LUMO) of compound **5**. Generally, the systems are characterized by relatively low energies for LUMO and LUMO+1 ([Table 7](#tbl7){ref-type="table"}). It is evident from [Fig. 7](#fig7){ref-type="fig"} that, in compound **5**, the LUMO resides in the imidazole moiety while the HOMO is intense on the ferrocene ring. The high energies obtained for HOMO and HOMO-1 reflect the ability of electron donation \[[@bib53]\]. Compound **3** has the highest HOMO and HOMO-1 values (-0.171 eV and -0.172 eV, respectively, [Table 7](#tbl7){ref-type="table"}), and this is due to the effect of the electron-donating group on the imidazole moiety, which increases the orbital energies of the ferrocenyl receptor \[[@bib54]\]. These results indicate that more energy is involved during the electron transition in the HOMO relative to LUMO. The difference between Ε~HOMO~ and E~LUMO~ yields the band gap energy (ΔE), which is an important stability index \[[@bib55]\]. A smaller band gap is a measure of greater prospect for transfer of electrons within a given system \[[@bib56]\]. Compounds **2** and **5** gave the smallest band gap energies of 0.073 and 0.085 eV, respectively ([Table 7](#tbl7){ref-type="table"}). The HOMO--LUMO energy gaps of compounds **1**--**6** was found to approximately agree with the band gap energies calculated from the electrochemical ([Table 7](#tbl7){ref-type="table"}). As illustrated in [Fig. 7](#fig7){ref-type="fig"}, excitation from lower to lowest unoccupied orbital reflects a localized density on the functional groups while the electrons are highly occupied in the parent (ferrocene) moiety. The results obtained in [Table 7](#tbl7){ref-type="table"} indicated that the ΔE corresponds to CT transitions in all the compounds.Fig. 7Lobes of the frontier molecular orbitals for the symmetric compound **5** obtained from the M1 theoretical model.Fig. 7Table 7Frontier molecular orbital energies and quantum chemical descriptors of compounds **1**--**6** obtained from M1 level of theory.Table 7CompoundLUMO+1 (eV)LUMO (eV)HOMO (eV)HOMO-1 (eV)ΔE[∗](#tbl7fnlowast){ref-type="table-fn"} (eV)ΔE (CV) (eV)**1**-0.045-0.046-0.172-0.1730.1270.073**2**-0.054-0.107-0.180-0.1810.0730.081**3**-0.044-0.045-0.171-0.1720.1260.070**4**-0.058-0.058-0.184-0.1850.1260.121**5**-0.115-0.115-0.200-0.2000.0850.070**6**-0.052-0.053-0.178-0.1790.1260.160[^3]

3. Conclusion {#sec3}
=============

Novel ferrocene derivatives, namely of compounds **4**--**6**, were synthesized and characterized. The single crystal X-ray crystallographic analysis of compounds **4** and **5** showed the preferred solid-state conformation and symmetry of the di-substituted ferrocenyl moiety. The electrochemical behaviour of the compounds was studied by cyclic voltammetry which shows one fully or partially reversible one-electron oxidation and one or two quasi-reversible reductions for the imidazole acceptor moieties with band gaps similar to those obtained from DFT calculations. The electron transfer process and redox behaviour of compounds **1**--**6** are affected by the electron-donating and withdrawing substituent on the imidazole moiety. Thus, the optical and electronic properties of the synthesized compounds can be fine-tuned by changing the substituent groups on the imidazole ring.

4. Experimental {#sec4}
===============

2-Nitro-1H-imidazole (≥98.1%), 2-chloro-1H-imidazole (≥98.2%), 2-methyl-1H-imidazole (\>98%), ferrocenemethanol (98%) and 1,1′-ferrocenedimethanol (98%) were supplied by Sigma Aldrich. Sodium borohydride (95%) and glacial acetic acid (99.8%) were supplied by Merck chemicals. All other solvents used were of analytical grade and were used as supplied by Sigma Aldrich, unless stated otherwise. TLC with varying solvent polarity was performed on silica gel 60 F~254~ plates. Silica gel with 0.063--0.2 mm mesh size was used for column chromatography to purify the products obtained. The melting point of each compound was determined using an open-end capillary tube in a Bibby Stuart Scientific model SMP3 apparatus. Infrared spectra were obtained with a PerkinElmer Spectrum 100 FTIR spectrometer fitted with a universal ATR accessory. ^1^H-NMR and ^13^C-NMR spectra were recorded on a 400 MHz Bruker AVANCE III spectrometer at room temperature using deuterated CDCl~3~ or DMSO as solvents. Mass spectra of the synthesized compounds were obtained from an Agilent Technologies, 1100 series, ion-trap mass spectrometer. Electronic spectra were recorded on a PerkinElmer Lambda 35 double-beam UV--visible spectrophotometer with 10 mm path length quartz cuvettes in acetonitrile, dichloromethane, and DMF. Cyclic voltammetry measurements were performed with a CHI660E electrochemical workstation (CH Instruments, USA) with a scan rate of 100 mV/s^−1^ in a three-electrode system consisting of a GCE (3.0 mm diameter) auxiliary electrode, Ag/AgCl reference electrode and a platinum-wire as the working electrode. The half-wave potential (E~1/2~)values were obtained using (E~pa~ + E~pc~)/2, where E~pa~ and E~pc~ are the anodic and cathodic peak potentials, respectively. The band gap energies were estimated from the empirical relation E~LUMO~ = \[(E~red~ - E~1/2~(ferrocene)) + 4.8\] eV or E~HOMO~ = \[(E~ox~ - E~1/2~(ferrocene)) + 4.4\] eV. Ferrocene was used as an external standard. It shows two peaks at 0.38 and 0.45 V hence the E~1/2~ (ferrocene) is equal to 0.42 V. The longest absorption wavelength λ~onset~ was used to calculate the optical gap energy, ΔE (Optical), according to the equation E~g~ = 1242/λ~onset~.

4.1. General procedure for the synthesis of compounds 4--6 {#sec4.1}
----------------------------------------------------------

### 4.1.1. Representative procedure for 4--6 {#sec4.1.1}

The prepared 1,1′-ferrocenedimethanol (240.9 mg, 1 mM) and 2-chloro-1H-imidazole (262.3 mg, 2.32 mM) in acetic acid (3 mL) were stirred for 6 hours at 60 °C. Product formation was monitored by using TLC plates with ethyl acetate/hexane (2:1) as eluent. The reaction mixture was extracted with ethyl acetate (50 mL), washed with 15 mL brine solution and dried over anhydrous sodium sulphate. Thereafter, the solvent was removed under reduced pressure to obtain the crude product which was purified by flash column chromatography on silica gel to give a yellow solid.

### 4.1.2. Synthesis of 1,1′-ferrocenylmethyl(2-chloroimidazole) (4) {#sec4.1.2}

The general procedure described in Section [4.1.1](#sec4.1.1){ref-type="sec"} was followed by using 1,1′-ferrocenedimethanol (246.0 mg, 1 mM) and 2-chloro-1H-imidazole (237.8 mg, 2.20 mM). The product was purified by column chromatography and concentrated under vacuum to obtain yellow crystals as the product. Yield: 60% (245.0 mg), R~f~ = 3.0, m.p = 170--174 °C. IR (cm^−1^): 439.01, 736.00, 820.00, 1036.00, 1334.37, 1465.70, 1702.04, 2923.79, 3100.43. ^1^H-NMR spectra (400 MHz, CDCl~3~, δ ppm): δ = 4.17--4.22 (8H, t, 2 C~5~H~4~), 4.76 (4H, s, 2 (CH~2~)), 6.85 (2H, s, imidazole CH=CH), 6.89 (2H, s, imidazole CH=CH) ppm. ^13^C-NMR spectra (400 MHz, CDCl~3~, δ ppm): δ = 14.11, 22.67, 29.64, 30.92, 45.87, 69.53, 69.71, 76.74, 77.06, 77.38, 82.63, 120.46, 128.15, 131.22, 206.98. HR-MS (C~18~H~16~Cl~2~FeN~4~). ES: \[M\]^+^ *m/z* calc. 414.00910, found \[M + Na\]^+^ 436.9902.

### 4.1.3. Synthesis of 1,1′-ferrocenyl(2-nitroimidazole) (5) {#sec4.1.3}

The general procedure described in Section [4.1.1](#sec4.1.1){ref-type="sec"} was followed by using 1,1′-ferrocenedimethanol (246.0 mg, 1 mM) and 2-nitro-1H-imidazole (262.3 mg, 2.32 mM). The product was purified by column chromatography and concentrated under vacuum to obtain orange crystals. Yield: 56% (242.2 mg), R~f~ = 0.59, m.p = 245 °C. IR (cm^−1^): 437.66, 831.62, 916.65, 1023.23, 1143.93, 1237.14, 1270.40, 1353.90, 1479.86, 1526.93, 1661.18, 2867.87, 3116.37, 3385.49. ^1^H-NMR spectra (400 MHz, CDCl~3~, δ ppm): δ = 4.23--4.25 (8H, t, 2 C~5~H~4~), 5.39 (4H, s, 2(CH~2~)), 7.15 (2H, s, imidazole CH=CH), 7.66 (2H, s, imidazole CH=CH) ppm. ^13^C-NMR spectra (400 MHz, CDCl~3~, δ ppm): δ = 30.89, 29.62, 39.83, 40.03, 49.28, 49.66, 60.22, 68.77, 69.86,70.26, 77.08, 77.33, 80.77, 81.57, 124.97, 128.02, 207.32. HR-MS (C~18~H~16~FeN~6~O~4~). ES: \[M\]^+^ *m/z* calc. 436.05800, found \[M + Na\]^+^ 459.04801.

### 4.1.4. Synthesis of 1,1′-ferrocenylmethyl(2-methylimidazole) (6) {#sec4.1.4}

The general procedure described in Section [4.1.1](#sec4.1.1){ref-type="sec"} was followed by using 1,1′-ferrocenedimethanol (246.0mg, 1 mM) and 2-methyl-1H-imidazole (190.5 mg, 2.32 mM). The product was purified by column chromatography and concentrated under vacuum to obtain orange solid. Yield: 64% (239.0 mg), R~f~ = 2.44, m.p = 258 °C; IR (cm^−1^): 487.66, 691.80, 831.62, 916.65, 1023.23, 1113.93, 1237.14, 1270.40, 1479.86, 1526.93, 1661.18, 2867.87, 3116.37, 3385.49. ^1^H-NMR spectra (400 MHz, CDCl~3~) 2.39 (6H, s, 2(CH~3~)), 4.14--4.23 (8H, t, 2 C~5~H~4~), 4.76 (4H, s, 2(CH~2~)), 6.77 (2H, s, imidazole), 6.83 (2H, s, imidazole CH=CH). ^13^C-NMR spectra (400 MHz, CDCl~3~): δ (ppm) = 10.96, 13.07, 14.05, 23.74, 28.92, 29.35, 30.35, 38.72, 45.42, 60.15, 61.58, 68.62, 69.04, 70.26, 72.66, 76.76, 77.07, 77.28, 89.00, 119.00, 126.32, 128.79, 130.89, 132.43, 143.93, 167.77. HR-MS (C~20~H~22~FeN~4~). ES: \[M\]^+^ *m/z* calc. 374.30012, found 374.30215.

4.2. X-ray crystal structures {#sec4.2}
-----------------------------

Crystals of compounds **4** and **5** were attached onto the tip of a glass fibre with epoxy glue and centered in the X-ray beam under a video camera. Crystal evaluation and data were done and collected on a Bruker Smart APEX2 diffractometer with Mo Kα radiation (λ = 0.71073 Å) equipped with an Oxford Cryostream low-temperature apparatus. Omega scans of 0.5° width with an exposure time of 20 s per frame were used for data collection. The total number of images was based on results from the program COSMO \[[@bib57]\] with the completeness of 100% out to 0.75 Å and expected redundancy was expected to be 4.0. The initial cell matrix was determined from three series of scans collected at intervals of 0.5° in a 6° range, with each of the series of scans collected at different starting angles and the APEXII \[[@bib58]\] program suite employed for reflection indexing. Cell parameters were retrieved using APEXII \[[@bib58]\] and refined by using SAINT \[[@bib59]\] on all observed reflections. The structures were solved by the direct method using the SHELXS \[[@bib60]\] program and refined. The visual crystal structures were presented using ORTEP-3 \[[@bib61]\] and MERCURY \[[@bib62]\]. Non-hydrogen atoms were first refined with anisotropic displacement parameter and then by anisotropic refinement with full-matrix least squares.

Ten different DFT models (B3LYP, \[[@bib63], [@bib64]\] B3LYP-D2, B3LYP-D3, \[[@bib65]\] CAM-B3LYP, \[[@bib66]\] BMK, M05-2X, M06, M06-2X, M06-HF and M06-L \[[@bib67], [@bib68]\]) with def2-TZVP \[[@bib69]\] and 6-311+G(d) \[[@bib70], [@bib71]\] basis sets were examined. M06-L \[[@bib68]\] plus either basis sets proved to be sufficient and more accurate than the rest of the DFT models studied. Calculations were executed within the Gaussian 09 RevD.01 software \[[@bib72]\] and pre/post molecular analyses were carried out in GaussView \[[@bib73]\].

### 4.2.1. Crystallographic data {#sec4.2.1}

Crystallographic data (excluding structure factors) have been deposited with the Cambridge Crystallographic Data Centre and can be obtained free of charge *via* [www.ccdc.cam.ac.uk/data_request/cif](http://www.ccdc.cam.ac.uk/data_request/cif){#intref0010}. The supplementary crystallographic data of compounds **4** and **5** are contained in CCDC 1854200 and 1854185 publication number, respectively.

Declarations {#sec5}
============

Author contribution statement {#sec5.1}
-----------------------------

Ayomide H. Labulo: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper.

Vincent O.Nyamori: Conceived and designed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.

Bernard Omandi: Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.

Funding statement {#sec5.2}
-----------------

This work was supported by University of KwaZulu-Natal (UKZN), UKZN Nanotechnology Platform, National Research Foundation (NRF) SA, and Eskom Tertiary Education Support Programme (TESP) SA.

Competing interest statement {#sec5.3}
----------------------------

The authors declare no conflict of interest.

Additional information {#sec5.4}
----------------------

No additional information is available for this paper.

[^1]: Values taken from ref \[[@bib29]\].

[^2]: E~pa~, anodic oxidation potential; E~pc~, cathodic reduction potential; $\text{~\!}E_{1/2\text{~\!}}$, redox peak potential; $(E_{1/2\text{~\!}}$ = (E~pa~ + E~pc~)/2); ΔE~p~ = E~pa~ - E~pc~.

[^3]: ΔE - calculated band gap energy.
